Works by Mager, Donald E.


Results: 71
    1
    2
    3
    4

    Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer.

    Published in:
    2020
    By:
    • Greene, Michelle K.;
    • Chen, Ting;
    • Robinson, Eifion;
    • Straubinger, Ninfa L.;
    • Minx, Charlene;
    • Chan, Darren K. W.;
    • Wang, Jun;
    • Burrows, James F.;
    • Van Schaeybroeck, Sandra;
    • Baker, James R.;
    • Caddick, Stephen;
    • Longley, Daniel B.;
    • Mager, Donald E.;
    • Straubinger, Robert M.;
    • Chudasama, Vijay;
    • Scott, Christopher J.
    Publication type:
    journal article
    5
    6

    Merging Systems Biology with Pharmacodynamics.

    Published in:
    Science Translational Medicine, 2012, v. 4, n. 126, p. 1, doi. 10.1126/scitranslmed.3003563
    By:
    • Iyengar, Ravi;
    • Zhao, Shan;
    • Chung, Seung-Wook;
    • Mager, Donald E.;
    • Gallo, James M.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain.

    Published in:
    Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.817236
    By:
    • Bloomingdale, Peter;
    • Meregalli, Cristina;
    • Pollard, Kevin;
    • Canta, Annalisa;
    • Chiorazzi, Alessia;
    • Fumagalli, Giulia;
    • Monza, Laura;
    • Pozzi, Eleonora;
    • Alberti, Paola;
    • Ballarini, Elisa;
    • Oggioni, Norberto;
    • Carlson, Louise;
    • Liu, Wensheng;
    • Ghandili, Mehrnoosh;
    • Ignatowski, Tracey A.;
    • Lee, Kelvin P.;
    • Moore, Michael J.;
    • Cavaletti, Guido;
    • Mager, Donald E.
    Publication type:
    Article
    20
    21
    22

    Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.

    Published in:
    CTS: Clinical & Translational Science, 2021, v. 14, n. 3, p. 908, doi. 10.1111/cts.12956
    By:
    • Zhu, Jing;
    • Campagne, Olivia;
    • Torrice, Chad D.;
    • Flynn, Gabrielle;
    • Miller, Jordan A.;
    • Patel, Tejendra;
    • Suzuki, Oscar;
    • Ptachcinski, Jonathan R.;
    • Armistead, Paul M.;
    • Wiltshire, Tim;
    • Mager, Donald E.;
    • Weiner, Daniel L.;
    • Crona, Daniel J.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Boolean network modeling in systems pharmacology.

    Published in:
    Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 1, p. 159, doi. 10.1007/s10928-017-9567-4
    By:
    • Bloomingdale, Peter;
    • Nguyen, Van Anh;
    • Niu, Jin;
    • Mager, Donald E.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Population pharmacokinetics of exenatide.

    Published in:
    British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 517, doi. 10.1111/bcp.13135
    By:
    • Cirincione, Brenda;
    • Mager, Donald E.
    Publication type:
    Article
    40
    41
    42
    43
    44

    Pharmacometrics and Systems Pharmacology 2030.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 76, doi. 10.1002/cpt.1683
    By:
    • Mentré, France;
    • Friberg, Lena E.;
    • Duffull, Stephen;
    • French, Jonathan;
    • Lauffenburger, Douglas A.;
    • Li, Lang;
    • Mager, Donald E.;
    • Sinha, Vikram;
    • Sobie, Eric;
    • Zhao, Ping
    Publication type:
    Article
    45

    Pharmacodynamic Drug–Drug Interactions.

    Published in:
    Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 6, p. 1395, doi. 10.1002/cpt.1434
    By:
    • Niu, Jin;
    • Straubinger, Robert M.;
    • Mager, Donald E.
    Publication type:
    Article
    46
    47
    48
    49
    50